Devyser BRCA NGS is a fast and robust NGS solution designed for the detection of genetic variants in the BRCA1 and BRCA2 genes. It offers comprehensive and uniform coverage of all coding exons and exon/intron junctions of both genes. In addition, it includes the detection of single nucleotide variants (SNVs), insertions/deletions (Indels), and copy number variations (CNVs), in both germline and somatic contexts.

Key Features

Comprehensive variant detection: Identifies relevant genetic variants in the BRCA1 and BRCA2 genes.
Fast workflow: optimized for rapid results with same-day library preparation and less than 45 minutes of hands-on time.
Identification of germline and somatic variants, including CNV detection.
Dedicated software: Provides automated, user-friendly analysis, with options for batch export and efficient variant analysis without the need for bioinformatics expertise.
Devyser BRCA NGS

Clinical Applications

It is intended for the comprehensive screening and characterization of BRCA1 and BRCA2, including SNV and CNV detection.

Intended Audience / User

Ideal for laboratories focused on the comprehensive screening and characterization of the BRCA1 and BRCA2 genes, including the detection of both SNVs and CNVs.

Benefits

Streamlined workflow: easy to implement and suitable for laboratories with varying sample volume needs. Ready-to-use reagents, ensuring a reproducible process and reducing the risk of sample mix-ups or contamination. Intuitive software: facilitates the interpretation of obtained data, reducing the need for bioinformatics intervention.

Technical Specifications

Starting material: Human genomic DNA extracted from whole blood or FFPE tissue.

Ordering Information

CE-IVD Kits
8-A100-8 8 tests
8-A100-24 24 tests
8-A100-96 96 tests
Accessories
8-A204 Devyser Library Clean
8-A200 Devyser Index Plate A

Other references: RUO version with references 8-A102-8, 8-A102-24, and 8-A102-96.

Area:

Hereditary cancer, Molecular Genetics, Solid tumor, Targeted study of specific pathologies

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Hedera Profiling RNA Test Panel

In‑house targeted enrichment NGS panel for RNA profiling from tissue samples (FFPE). It analyzes 43 genes using a splice‑aware probe design anchored to exon boundaries. Detects fusions in a partner-agnostic manner, complex splicing variants, and gene expression profiles in a single workflow. Detailed Description Principle of operation End‑to‑end solution based on hybrid capture enrichment chemistry…
HederaDx
Next Generation Sequencing (NGS)

Hedera Profiling ctDNA 3

In‑house targeted enrichment NGS panel exclusively for liquid biopsy (cfDNA). It analyzes 43 genes with ESCAT I and II clinical evidence. Includes library preparation through an optimized workflow (DNA‑only) for plasma samples. Detects SNVs, Indels, CNVs, fusions and 36 microsatellite instability (MSI) markers. Detailed Description Principle of operation End‑to‑end solution based on hybridisation and capture…
HederaDx
Next Generation Sequencing (NGS)

Hedera Profiling 1 FFPE Test Panel (HP1)

In‑house targeted enrichment NGS panel for pan‑cancer solid tumor profiling. It analyzes 115 genes (79 with complete CDS) with ESCAT I, II and III clinical evidence. Includes library preparation through a flexible workflow that allows processing FFPE and cfDNA samples together or separately. Detects SNVs, Indels, CNVs, fusions, structural variants and MSI. Detailed Description PRINCIPLE…
HederaDx
Next Generation Sequencing (NGS)

Sepsis Pathogenic Microorganism Detection Kit (Digital PCR)

In vitro diagnostic kit based on droplet digital PCR (dPCR) for the detection of pathogenic microorganisms associated with sepsis from DNA extracted from clinical samples. The kit allows identification and quantification of pathogens without requiring blood culture, covering 21 frequent agents in bloodstream infections. Detailed Description Principle of operation The Sepsis Pathogenic Microorganism Detection Kit…
RainSure
Digital PCR